| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/21/2008 | CA2658843A1 Crystalline antifungal compounds |
| 02/21/2008 | CA2650206A1 Novel crystal of 5-aminolevulinic acid phosphate and process for producing the same |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889843A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 02/20/2008 | EP1889841A1 Crystal of salt of benzimidazole compound |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1889831A2 Diazenedicarboxamides as inhibitors of D-alanine: D-alanine ligase (Ddl) |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889609A2 Immune response modifier foam formulations |
| 02/20/2008 | EP1888597A2 Antibacterial agents |
| 02/20/2008 | EP1888587A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c |
| 02/20/2008 | EP1888580A2 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 02/20/2008 | EP1888574A2 New antibiotic derivatives |
| 02/20/2008 | EP1888573A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888564A2 Benzofuran compounds |
| 02/20/2008 | EP1888507A1 Tigecycline and methods of preparation |
| 02/20/2008 | EP1888109A2 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/20/2008 | EP1888106A2 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 02/20/2008 | EP1888087A1 Ethanolic extract of animal origin combined with enzymes acts therapeutically on malignant and other diseases. |
| 02/20/2008 | EP1888079A2 Use of polyamines with antibiotics |
| 02/20/2008 | EP1888063A1 Antifungal agents |
| 02/20/2008 | EP1888054A2 Antimicrobial composition |
| 02/20/2008 | EP1887864A1 Method and composition for use in preparation of a patient for surgery |
| 02/20/2008 | EP1722771A4 Compositions and methods for preventing or treating an inflammatory response |
| 02/20/2008 | EP1581226B1 Inclusion complex of anti-tubercular rifampicin with beta-cyclodextrin or 2-hydroxypropyl beta-cyclodextrin and a process for producing the same |
| 02/20/2008 | EP1575600B1 Cosmetic preparations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride |
| 02/20/2008 | EP1556381B1 Pyrazole amides for treating hiv infections |
| 02/20/2008 | EP1521581B1 Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis |
| 02/20/2008 | EP1515729B1 Quaternised ammonium cyclodextrin compounds |
| 02/20/2008 | EP1427417B1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1404704B9 Bridged bicyclic serine protease inhibitors |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1289548B1 Immune system stimulating means |
| 02/20/2008 | EP1285947B1 Antimicrobial composition |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1154791B1 Neisserial vaccine compositions and methods |
| 02/20/2008 | EP1131290B1 Piperidine ccr-3 receptor antagonists |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | EP1101497B1 Stabilized oily preparations of tobicillin (beta-lactam antibiotic) |
| 02/20/2008 | EP1100922B1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/20/2008 | EP1099759B1 Vibrio cholerae vaccine candidates and methods of their constructing |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0951281B9 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR |
| 02/20/2008 | EP0938315B9 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128474A Tricyclic-nucleoside prodrugs for treating viral infections |
| 02/20/2008 | CN101128469A 蛋白酶抑制剂前体的合成 Synthetic precursor protease inhibitors |
| 02/20/2008 | CN101128455A Heterocyclylamide-substituted imidazoles |
| 02/20/2008 | CN101128434A Amide derivatives |
| 02/20/2008 | CN101128215A Immunogenic composition for use in vaccination against staphylococcei |
| 02/20/2008 | CN101128206A Tetracycline metal complex in a solid dosage form |
| 02/20/2008 | CN101128122A Fermented tea beverage and tea beverage |
| 02/20/2008 | CN101126095A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126094A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101125890A Monoclonal antibody for resisting bovine prion protein and application thereof |
| 02/20/2008 | CN101125871A Sulfuric acid azithromycin, application thereof, freeze dried of the sulfuric acid azithromycin and preparation method for the freeze dried |
| 02/20/2008 | CN101125850A Andrographolide derivatives and application of the same in pharmacy |
| 02/20/2008 | CN101125202A Protein vaccine used for processing immune tolerant treatment to hepatitis B |
| 02/20/2008 | CN101125192A Granule preparation for preventing and treating viral hepatitis associated with liver blood stasis |
| 02/20/2008 | CN101125190A Powdered medicine active carbon mixture and preparation method thereof |
| 02/20/2008 | CN101125187A Traditional Chinese medicinal plaster for treating pulmonary tuberculosis |
| 02/20/2008 | CN101125167A Medicine for treating influenza |
| 02/20/2008 | CN101125153A Acanthopanax root granule and its preparation method |
| 02/20/2008 | CN101125130A Indian chrysanthemum effervescent preparation and preparation method thereof |
| 02/20/2008 | CN101124992A 'Jinsuoyinkai' health-care sugar and production technology thereof |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369904C 2-(replace- amino)-NOBS HIV prolease inhibitor |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/19/2008 | US7332602 Pyridyl substituted heterocycles useful for treating or preventing HCV infection |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/19/2008 | US7332485 Peptide deformylase inhibitors |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/19/2008 | US7332476 Therapy for bacteria infections |
| 02/19/2008 | US7332475 administering a nasal aerosol comprising at least one member selected from reduced and oxidized glutathiones and pharmaceutically acceptable salts thereof and catechin; Coronavirus family or Flavivirus family |
| 02/19/2008 | US7332471 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332173 Group A streptococcal polysaccharide immunogenic compositions and methods |
| 02/19/2008 | US7332169 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine |
| 02/19/2008 | US7332166 Glycosylated specificity exchangers |
| 02/19/2008 | US7331951 Devices and methodologies useful in body aesthetics |
| 02/19/2008 | US7331920 Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same |
| 02/19/2008 | CA2436572C Perylenequinones for use as photosensitizers and sonosensitizers |
| 02/19/2008 | CA2380924C Compositions for treating viral infections, and methods therefor |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2324217C Process for the synthesis of hiv protease inhibitors |
| 02/19/2008 | CA2316310C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/19/2008 | CA2310049C Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 02/19/2008 | CA2218553C 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection |
| 02/19/2008 | CA2216856C Methods of screening for therapeutic agents using novel apoptosis-modulating proteins |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA2171699C Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
| 02/19/2008 | CA2121364C Vaccines for actinobacillus pleuropneumoniae |
| 02/14/2008 | WO2008019240A2 3, 6-bridged tylosin derivatives |